Login / Signup

Prospective evaluation of plasma Epstein-Barr virus DNA clearance and fluorodeoxyglucose positron emission scan in assessing early response to chemotherapy in patients with advanced or recurrent nasopharyngeal carcinoma.

Brigette MaEdwin P HuiAnn D KingSing F LeungMichael Km KamFrankie MoLeung LiKi WangHerbert LoongAshley WongCharles Ml ChanK C Allen ChanS C Cesar WongY M Dennis LoAnthony Tc Chan
Published in: British journal of cancer (2018)
Early PET-CT response and pEBV DNA clearance could predict survival and subsequent response. This dual endpoint is an innovative tool for assessing early drug response.
Keyphrases